By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Nurix, Inc. 

1700 Owens Street
Suite 205
San Francisco  California  94158  U.S.A.
Phone: 415-660-5320 Fax: 415-525-4200


Nurix, Inc. is a privately-held San Francisco-based biotechnology company that is focused on bringing novel, first-in-class therapies to patients. Nurix is a leader in discovering a new class of drugs that work by modulating the protein degradation of the cell. The Nurix scientific team has established an innovative drug discovery platform based on recent advances in understanding the ubiquitin proteasome system (UPS). Nurix was founded by internationally-recognized experts in the UPS field and is funded by leading life sciences investors, Third Rock Ventures and The Column Group. In September 2015 Nurix entered into an exclusive collaboration with Celgene for the discovery and development of next-generation therapies targeting protein homeostasis in oncology, immunology and inflammation, including the rapidly-evolving field of immune-oncology.

Key Statistics

Ownership: Private

Web Site: Nurix



Company News
Nurix Appoints Robert Tjian, Ph.D. Of The Column Group To Its Board Of Directors 12/7/2016 9:50:11 AM
Nurix Appoints Robert Tjian, Ph.D. Of The Column Group To Its Board Of Directors 12/6/2016 12:01:43 PM
Nurix Strengthens Executive Leadership Team 5/3/2016 11:27:27 AM
Nurix Announces New Appointments To Its Board Of Directors 5/3/2016 11:26:17 AM
Celgene (CELG), Nurix Team Up on $150M Drug Development Deal 9/16/2015 8:36:46 AM
Nurix Launches Collaboration With Mount Sinai Hospital’s Lunenfeld-Tanenbaum Research Institute To Expand Its Drug Discovery Program 12/2/2014 9:59:52 AM
Nurix Names Arthur T. Sands, M.D., Ph.D., Chief Executive Officer 9/18/2014 6:33:32 AM
San Francisco Biotech Startup Nurix Taps $25.1 Million Financing 5/22/2014 7:16:48 AM
Two San Francisco Startups, Element Science And Nurix, Reap Cash From Third Rock Ventures' Rich Funding Round 4/24/2014 7:33:47 AM